CHRISTOPHER READING - 20 Aug 2021 Form 4 Insider Report for BIOVIE INC. (BIVI)

Role
EVP Neuroscience R&D
Signature
/s/ Joanne Wendy Kim as Attorney-In-Fact
Issuer symbol
BIVI
Transactions as of
20 Aug 2021
Net transactions value
$0
Form type
4
Filing time
08 Oct 2021, 14:59:23 UTC
Previous filing
08 Oct 2021
Next filing
18 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIVI Stock Option (right to buy) Award $0 +124,167 $0.000000 124,167 20 Aug 2021 Common Stock 124,167 $7.74 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was 20% vested upon grant, with an additional 16% on each of the first five anniversaries of the grant.